The mother to child transmission of hepatitis B can be prevented by immunizing infants whose mothers suffer from hepatitis B, according to a BMJ published study. The world has a total of 350 million people who are carriers of hepatitis B, which is transmitted through body fluids and blood.
As many as 50% of these infections are accounted for by mother to child transmissions. The effects, both harmful and beneficial, have been researched with regard to hepatitis B immunoglobulin and hepatitis B vaccines for the hepatitis B surface antigen in newborn babies.
The occurrence of the infection is reported to have been prevented by administering the hepatitis B immunoglobulin, hepatitis B vaccine, or a combination of both, along with immunoglobulin. The combination with the immunoglobulin was seen to be the better and more effective alternative. Further research however is required with regard to the optimal dose.